1h Free Analyst Time
The molecular biology enzymes, kits, and reagents market is forecasted to grow by USD 10.56 billion during 2024-2029, accelerating at a CAGR of 9.5% during the forecast period. The report on the molecular biology enzymes, kits, and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic and chronic diseases, increasing funding and investment, and growth of personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The molecular biology enzymes, kits, and reagents market is segmented as below:
By Product
- Kits and reagents
- Enzymes
By Application
- Sequencing
- PCR
- Epigenetic
- Cloning
- Others
By End-user
- Biotech and pharma companies
- Research and academic institutes
- Hospitals and diagnostic centers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the molecular biology enzymes, kits, and reagents market covers the following areas:
- Molecular Biology Enzymes, Kits, And Reagents Market sizing
- Molecular Biology Enzymes, Kits, And Reagents Market forecast
- Molecular Biology Enzymes, Kits, And Reagents Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Application
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global molecular biology enzymes, kits, and reagents market: Agilent Technologies Inc., altona Diagnostics GmbH, Bio Rad Laboratories Inc., Bio Techne Corp., BioEcho Life Sciences GmbH, Cipla Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genes2Me Pvt. Ltd., HiMedia Laboratories, Illumina Inc., Intact Genomics Inc, LGC Science Group Holdings Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of automation and high-throughput technologies."
According to the report, one of the major drivers for this market is the rising prevalence of genetic and chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- altona Diagnostics GmbH
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- BioEcho Life Sciences GmbH
- Cipla Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Genes2Me Pvt. Ltd.
- HiMedia Laboratories
- Illumina Inc.
- Intact Genomics Inc
- LGC Science Group Holdings Ltd.
- Lonza Group Ltd.
- Merck KGaA
- New England Biolabs Inc.
- Promega Corp.
- Sartorius AG
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
